Clinical Trial Update: Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating pulsed paclitaxel in combination with daily thoracic radiotherapy for inoperable or unresectable non-small cell lung cancer; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: University of Rochester | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-01-30